发明名称 ACYLATED AMINOALKYLIMIDAZOLES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION
摘要 organic chemistry, chemical technology, pharmacy. SUBSTANCE: invention describes acylated aminoalkylimidazoles of the general formula (I) where R1 means phenyl group possibly monosubstituted with halogen atom or 1-naphthyl group; R2 means hydrogen atom; or R1 is hydrogen atom and R2 is pyridyl or 2-(5-chloro)-pyridyl group; R3 is halogen atom or C1-4-alkoxy-group. Described compounds can be in free form or in the form of salts. Compounds of the formula (I) show capability to inhibit activity of 25-hydroxy-vitamin D3 hydroxylase selectively. Invention describes also method of their synthesis and pharmaceutical composition based on compound of the formula (I). EFFECT: improved method of synthesis, valuable biochemical properties of compounds. 6 cl, 12 ex
申请公布号 RU2152933(C2) 申请公布日期 2000.07.20
申请号 RU19950107652 申请日期 1995.05.16
申请人 NOVARTIS AG 发明人 SHUSTER INGEBORG;EHGGER KHEL'MUT
分类号 C12N9/99;A61K31/00;A61K31/41;A61K31/415;A61K31/4164;A61K31/417;A61K31/4196;A61K31/44;A61K31/4427;A61K31/4433;A61K31/4439;A61P17/00;A61P17/04;A61P17/06;A61P17/14;A61P19/00;A61P19/08;A61P29/00;A61P43/00;C07D233/54;C07D233/60;C07D233/61;C07D249/02;C07D249/08;C07D401/06;C07D409/06;C07D521/00;(IPC1-7):C07D233/54;A61K31/416 主分类号 C12N9/99
代理机构 代理人
主权项
地址